相关实验视频
Updated: May 28, 2025

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation
Published on: July 27, 2022
肠道微生物群没有被放射性治疗显著改变
Pedro Barata1,2, Ana Oliveira3, Raquel Soares4
1RISE-Health, Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Fundação Ensino e Cultura Fernando Pessoa, Rua Carlos da Maia 296, 4200-150 Porto, Portugal.
甲状腺癌和甲状腺功能障碍症的放射性治疗 (RA I) 并没有显著改变肠道微生物群的多样性或丰富性. 与放射治疗不同,RAI对肠道微生物组合的影响最小.
科学领域:
- 核医学是一种核医学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 众所周知,放射治疗会破坏肠道微生物群.
- 核医学治疗,特别是放射性疗法 (RA I) 对肠道微生物群的影响尚不清楚.
- 射线治疗从根本上不同于放射治疗.
研究的目的:
- 研究RAI对肠道微生物群的影响.
- 为了比较RAI与放射治疗对肠道微生物群的影响.
- 分析RAI治疗后肠道微生物群丰富度,多样性和组成的变化.
主要方法:
- 这是一项前性研究,涉及64名因甲状腺癌或甲状腺功能障碍而接受RAI的患者.
- 在治疗前和治疗后8-10天收集的便样本.
- 枪支元基因组学和LEfSe分析,以评估肠道微生物群的丰富性,多样性和组成.
主要成果:
- 肠道微生物组的丰富性和多样性在RA I后保持不变.
- 观察到肠道微生物群组成的最小变化.
- 这些变化在甲状腺功能障碍症患者中特别有限.
结论:
- RA I似乎不会对人类肠道微生物群造成重大破坏.
- 这一发现与已知的放射治疗效应形成鲜明对比.
- 这项研究为了解放射性药物对肠道微生物群的影响提供了基础.
更多相关视频
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
What is Monogastric Digestion?
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

